Next Quarterly Earnings
Monday, March 22, 2027
Expected
Sichuan Kelun-Biotech Biopharmaceutical H is a leading biopharmaceutical company focused on innovative cancer therapies. The company develops highly effective antibody-drug conjugates (ADCs) and specializes in the research and clinical development of novel oncology drugs.
Sichuan Kelun-Biotech Biopharmaceutical H last reported quarterly earnings on 8/17/2026 (Q2 2026). Earnings per share (EPS) came in at 1.92 HKD.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.